The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms (BY1023/NL511)

NCT00449813 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
40
Enrollment
INDUSTRY
Sponsor class

Stopped Inclusion-rate does not seem feasible anymore to obtain te required number of patients before the end of the trial.

Conditions

Interventions

Sponsor

Takeda